Cabaletta Bio (NASDAQ:CABA) and La Jolla Pharmaceutical (NASDAQ:LJPC) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership. Insider and Institutional Ownership 68.0% of Cabaletta Bio shares are held by institutional investors. […]